What is Global Gastroparesis Treatment Products Market?
The Global Gastroparesis Treatment Products Market is a vast and dynamic sector that focuses on the development and distribution of products aimed at treating gastroparesis, a condition that affects the normal spontaneous movement of the muscles in your stomach. This market is a subset of the broader pharmaceutical industry and includes a variety of products such as drugs and surgical treatment products. The market is driven by the increasing prevalence of gastroparesis worldwide and the ongoing research and development activities in the field of gastroenterology. The market is also influenced by factors such as the availability of effective treatment options, the increasing awareness about the condition, and the growing healthcare expenditure in various regions across the globe.
Drugs, Surgical Treatment Products in the Global Gastroparesis Treatment Products Market:
The Global Gastroparesis Treatment Products Market is segmented into drugs and surgical treatment products. Drugs for gastroparesis treatment include prokinetic agents and antiemetic agents. Prokinetic agents help to speed up gastric emptying and reduce symptoms of gastroparesis, while antiemetic agents help to control nausea and vomiting, which are common symptoms of the condition. On the other hand, surgical treatment products include gastric electrical stimulation devices and feeding tubes. Gastric electrical stimulation devices use mild electrical pulses to stimulate the muscles in the lower part of the stomach, helping to control vomiting and nausea. Feeding tubes, on the other hand, are used in severe cases of gastroparesis where the patient is unable to maintain adequate nutrition orally.
Hospital Pharmacies, Private Clinics, Drug Stores, E-Commerce in the Global Gastroparesis Treatment Products Market:
The Global Gastroparesis Treatment Products Market finds its usage in various areas such as hospital pharmacies, private clinics, drug stores, and e-commerce. Hospital pharmacies are the primary distribution channel for gastroparesis treatment products. They stock a wide range of drugs and surgical treatment products and are often the first point of contact for patients seeking treatment for gastroparesis. Private clinics also play a significant role in the distribution of these products, especially in regions where hospital pharmacies are not easily accessible. Drug stores and e-commerce platforms have also emerged as important distribution channels, especially for over-the-counter drugs used in the treatment of mild cases of gastroparesis.
Global Gastroparesis Treatment Products Market Outlook:
The Global Gastroparesis Treatment Products Market has shown a steady growth over the years. In 2023, the market was valued at US$ 5659 million and is expected to reach US$ 7087.5 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030. This growth can be attributed to the increasing prevalence of gastroparesis and the continuous advancements in the field of gastroenterology. The global pharmaceutical market, of which the gastroparesis treatment products market is a part, is also growing at a steady pace. In 2022, the global pharmaceutical market was valued at 1475 billion USD and is expected to grow at a CAGR of 5% over the next six years. The chemical drug market, a significant segment of the pharmaceutical industry, is also expected to see growth, increasing from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022.
| Report Metric | Details |
| Report Name | Gastroparesis Treatment Products Market |
| Accounted market size in 2023 | US$ 5659 million |
| Forecasted market size in 2030 | US$ 7087.5 million |
| CAGR | 3.2% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm, Ani Pharmaceuticals, Medtronic, Boston Scientific |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
